New Delhi: Pfizer’s Biontech vaccine has been shown to be effective and safe for 5- to 11-year-olds. The vaccinated children developed antibodies to the Kovid 19 virus. So now the way is open to ask for emergency permission to use Pfizer’s vaccine for children.
Children between the ages of five and eleven were given two doses of 10 micrograms, which showed good results. Even well-developed antibodies can fight off the Covid 19 virus. A dose of 30 micrograms was used in the age group of 12 years and above. They were given two doses 21 days apart. Vaccines were found to be safe, tolerable and effective between the ages of five and eleven. It has also been shown that these children develop sufficient antibodies against the Covid 19 virus.
The company said in a statement that it would now apply to the US Food and Drug Administration, the European Drug Administration and other regulatory bodies for an emergency license to use the vaccine for children. The number of patients in the United States has risen by 240 percent since July, underscoring the importance of public health. Albert Borla, president and chief executive officer of Pfizer, said the current tests have paved the way for children to seek permission to use the vaccine. Bioentech chief executive officer and co-founder Ugur Sahin said the details of the tests on children would be submitted to regulators soon. The first, second and third phase tests involved 4,500 children aged 6 months to 11 years. Ninety percent of the tests were performed in the United States, Finland, Poland, and Spain.
Notice to the Center regarding vaccination of pregnant women
New Delhi: The Supreme Court has issued notice to the Center on a petition seeking priority in the covid vaccination program for pregnant women and lactating mothers and asked them to file a statement within two weeks.
The petition was filed by the Delhi Commission for the Protection of Child Rights. Take it on. Dhananjay Chandrachud, Justice. B.V. Nagaratna has issued a show cause notice. Speaking on behalf of the organization, Vrinda Grover said that the Center had issued some guidelines on vaccination of pregnant women. But now it has been suggested that vaccinations are having an adverse effect on them. Mothers in this group need to be included in the risk group and need to know what effect vaccination has on them.
A list of pregnant and lactating mothers needs to be prepared and monitored. Taking note of the petition, the court said that the petition was filed under Article 32 in May, after which guidelines on immunization of pregnant and lactating mothers were issued.
The court has issued a notice to the Center seeking a reply within two weeks. The court sought the help of Solicitor General Tushar Mehta to clarify the policy on vaccination of these women. The court has asked what further steps have been taken in this regard.